TY - JOUR
T1 - Human hypertension caused by mutations in WNK kinases
AU - Wilson, FH
AU - Disse-Nicodeme, S
AU - Choate, KA
AU - Ishikawa, K
AU - Nelson-Williams, C
AU - Desitter, I
AU - Gunel, M
AU - Milford, David
AU - Lipkin, Graham
AU - Achard, JM
AU - Feely, MP
AU - Dussol, B
AU - Berland, Y
AU - Unwin, RJ
AU - Mavan, H
AU - Simon, DB
AU - Farfel, Z
AU - Jeunemaitre, X
AU - Lifton, RP
PY - 2001/8/10
Y1 - 2001/8/10
N2 - Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion. Both genes encode members of the WNK family of serine-threonine kinases. Disease-causing mutations in WNK1 are large intronic deletions that increase WNK1 expression. The mutations in WNK4 are missense, which cluster in a short, highly conserved segment of the encoded protein. Both proteins localize to the distal nephron, a kidney segment involved in salt, K+, and pH homeostasis. WNK1 is cytoplasmic, whereas WNK4 localizes to tight junctions. The WNK kinases and their associated signaling pathway(s) may offer new targets for the development of antihypertensive drugs.
AB - Hypertension is a major public health problem of largely unknown cause. Here, we identify two genes causing pseudohypoaldosteronism type II, a Mendelian trait featuring hypertension, increased renal salt reabsorption, and impaired K+ and H+ excretion. Both genes encode members of the WNK family of serine-threonine kinases. Disease-causing mutations in WNK1 are large intronic deletions that increase WNK1 expression. The mutations in WNK4 are missense, which cluster in a short, highly conserved segment of the encoded protein. Both proteins localize to the distal nephron, a kidney segment involved in salt, K+, and pH homeostasis. WNK1 is cytoplasmic, whereas WNK4 localizes to tight junctions. The WNK kinases and their associated signaling pathway(s) may offer new targets for the development of antihypertensive drugs.
U2 - 10.1126/science.1062844
DO - 10.1126/science.1062844
M3 - Article
C2 - 11498583
SN - 1095-9203
VL - 293
SP - 1107
EP - 1112
JO - Science
JF - Science
ER -